OVERWEIGHT OR OBESITY AND ELEVATED LIVER FAT

Clinical trials for OVERWEIGHT OR OBESITY AND ELEVATED LIVER FAT explained in plain language.

Never miss a new study

Get alerted when new OVERWEIGHT OR OBESITY AND ELEVATED LIVER FAT trials appear

Sign up with your email to follow new studies for OVERWEIGHT OR OBESITY AND ELEVATED LIVER FAT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug aims to shrink dangerous liver fat and shed pounds

Disease control Recruiting now

This study is testing whether an investigational drug called maridebart cafraglutide, combined with a reduced-calorie diet and exercise, is better than a placebo at reducing liver fat and body weight. It will involve about 180 adults who are overweight or have obesity and have hi…

Matched conditions: OVERWEIGHT OR OBESITY AND ELEVATED LIVER FAT

Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

OVERWEIGHT OR OBESITY AND ELEVATED LIVER FAT

Get alerted when new OVERWEIGHT OR OBESITY AND ELEVATED LIVER FAT trials appear

New drug aims to shrink dangerous liver fat and shed pounds